Medicyte GmbH Signs Agreement with Life Technologies to Develop Next Generation Upcyte® Cells

News   Mar 28, 2013

 
Medicyte GmbH Signs Agreement with Life Technologies to Develop Next Generation Upcyte® Cells
 
 
 

RELATED ARTICLES

PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery Programs

News

PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.

READ MORE

Glial-Neuronal Interaction Fundamental for Memory

News

When astrocytes in mice overproduce a protein called ephrin-B1, the ability of the animal to retain memory weakens.

READ MORE

Novel Method for Testing Vaccine Safety

News

Scientists from the Institut Pasteur, the CNRS and Sanofi Pasteur have recently developed a novel alternative method to animal testing that can be used to verify the safety of vaccines such as the yellow fever vaccine.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy